药学与临床研究2024,Vol.32Issue(1) :6-11.

氨甲环酸醇质体的制备及体外评价

Preparation and in vitro Evaluation of Tranexamic Acid Ethosomes

余胜男 姜伟化 杜子蝶 李念光 刘飞
药学与临床研究2024,Vol.32Issue(1) :6-11.

氨甲环酸醇质体的制备及体外评价

Preparation and in vitro Evaluation of Tranexamic Acid Ethosomes

余胜男 1姜伟化 2杜子蝶 2李念光 1刘飞2
扫码查看

作者信息

  • 1. 江苏省中药资源产业化过程协同创新中心 南京中医药大学,南京 210000
  • 2. 南京迈诺威医药科技有限公司,南京 210000
  • 折叠

摘要

目的:制备氨甲环酸醇质体(TA@ES),并初步考察其体外透皮性能.方法:采用乙醇注入-挤出法制备TA@ES.通过单因素考察和Box-Behnken设计-响应面法对处方进行筛选及优化;按最优处方制备TA@ES,对其进行质量评价,并进行体外透皮试验.结果:优化后的TA@ES处方脂药比为3.20∶1,胆固醇用量为0.62%,乙醇用量为19.37%.制得的TA@ES为类球形,平均粒径为(194.3±4.1)nm,Zeta电位为(-32.2±2.6)mV,包封率为(17.20±0.89)%.体外透皮试验结果表明,与氨甲环酸水溶液相比,TA@ES不仅提高了药物经皮渗透量(4.98倍),而且还增加了深层皮肤滞留量(1.74倍).结论:制备的TA@ES能够提高氨甲环酸的经皮渗透量和深层皮肤滞留量,有望成为黄褐斑治疗药物的新载体.

Abstract

Objective:To prepare tranexamic acid ethosomes(TA@ES),and preliminarily investigate their in vitro permeation.Methods:TA@ES were prepared by an ethanol injection-extrusion method.The formulation was studied by a single-factor method,and then optimized by the Box-Behnken design-response surface method.TA@ES prepared according to the optimal prescription were evaluated for their quality and in vitro permeation.Results:The optimal formulation was as follows:the ratio of phospholipids to tranex-amic acid was 3.20∶1,the dosage of cholesterol was 0.615%,and the dosage of ethanol was 19.366%.The mean particle size of the prepared TA@ES was(194.3±4.1)nm,the Zeta potential was(-32.2±2.6)mV,and the encapsulation efficiency was(17.20%±0.89%).The results of in vitro permeation test showed that the TA@ES not only increased the permeation penetration of the drug(4.98 times),but also increased the deep skin retention(1.74 times),as compared to tranexamic acid aqueous solution.Conclusion:The pre-pared TA@ES can improve the percutaneous penetration and deep skin retention of tranexamic acid,which is expected to be a new vehicle for melasma treatment.

关键词

氨甲环酸/醇质体/Box-Behnken设计-响应面法/体外透皮试验

Key words

Tranexamic acid/Ethosomes/Box-Behnken design-response surface method/In vitro per-meation test

引用本文复制引用

出版年

2024
药学与临床研究
江苏省药学会

药学与临床研究

CSTPCD
影响因子:0.95
ISSN:1673-7806
参考文献量20
段落导航相关论文